-
1
-
-
33646055453
-
Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings
-
Hishinuma S, Ogata Y, Tomikawa M, et al. Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings. J Gastrointest Surg 2006; 10: 511-518.
-
(2006)
J Gastrointest Surg
, vol.10
, pp. 511-518
-
-
Hishinuma, S.1
Ogata, Y.2
Tomikawa, M.3
-
2
-
-
62249176551
-
DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer
-
Iacobuzio-Donahue CA, Fu B, Yachida S, et al. DPC4 gene status of the primary carcinoma correlates with patterns of failure in patients with pancreatic cancer. J Clin Oncol 2009; 27: 1806-1813.
-
(2009)
J Clin Oncol
, vol.27
, pp. 1806-1813
-
-
Iacobuzio-Donahue, C.A.1
Fu, B.2
Yachida, S.3
-
3
-
-
0021867923
-
Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection
-
Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg 1985; 120: 899-903.
-
(1985)
Arch Surg
, vol.120
, pp. 899-903
-
-
Kalser, M.H.1
Ellenberg, S.S.2
-
4
-
-
35648958698
-
Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: Long-term results of EORTC trial 40891
-
Smeenk HG, van Eijck CH, Hop WC, et al. Long-term survival and metastatic pattern of pancreatic and periampullary cancer after adjuvant chemoradiation or observation: long-term results of EORTC trial 40891. Ann Surg 2007; 246: 734-740.
-
(2007)
Ann Surg
, vol.246
, pp. 734-740
-
-
Smeenk, H.G.1
van Eijck, C.H.2
Hop, W.C.3
-
5
-
-
12144287320
-
A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer
-
Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004; 350: 1200-1210.
-
(2004)
N Engl J Med
, vol.350
, pp. 1200-1210
-
-
Neoptolemos, J.P.1
Stocken, D.D.2
Friess, H.3
-
6
-
-
58749093918
-
Final results of the randomized, prospective multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation alone in patients with resected pancreatic cancer
-
abstract #4504
-
[Neuhaus P, Riess H, Post S, et al. Final results of the randomized, prospective multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation alone in patients with resected pancreatic cancer. J Clin Oncol 2008; 26: abstract #4504.
-
(2008)
J Clin Oncol
, vol.26
-
-
Neuhaus, P.1
Riess, H.2
Post, S.3
-
7
-
-
0033497862
-
Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: Phase III trial of the EORTC gastrointestinal tract cancer cooperative group
-
Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group. Ann Surg 1999; 230: 776-782.
-
(1999)
Ann Surg
, vol.230
, pp. 776-782
-
-
Klinkenbijl, J.H.1
Jeekel, J.2
Sahmoud, T.3
-
8
-
-
40449113435
-
Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: A randomized controlled trial
-
Regine WF, Winter KA, Abrams RA, et al. Fluorouracil vs gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA 2008; 299: 1019-1026.
-
(2008)
JAMA
, vol.299
, pp. 1019-1026
-
-
Regine, W.F.1
Winter, K.A.2
Abrams, R.A.3
-
9
-
-
58749092114
-
Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: Composite data from the ESPAC-1 and -3(v1) trials
-
Neoptolemos JP, Stocken DD, Tudur Smith C, et al. Adjuvant 5-fluorouracil and folinic acid vs observation for pancreatic cancer: composite data from the ESPAC-1 and -3(v1) trials. Br J Cancer 2009; 100: 246-250.
-
(2009)
Br J Cancer
, vol.100
, pp. 246-250
-
-
Neoptolemos, J.P.1
Stocken, D.D.2
Tudur Smith, C.3
-
10
-
-
77956416112
-
Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: A randomized controlled trial
-
Neoptolemos JP, Stocken DD, Bassi C, et al. Adjuvant chemotherapy with fluorouracil plus folinic acid vs gemcitabine following pancreatic cancer resection: a randomized controlled trial. JAMA 2010; 304: 1073-1081.
-
(2010)
JAMA
, vol.304
, pp. 1073-1081
-
-
Neoptolemos, J.P.1
Stocken, D.D.2
Bassi, C.3
-
11
-
-
49049097154
-
Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: The Mayo Clinic experience (1975-2005)
-
Corsini MM, Miller RC, Haddock MG, et al. Adjuvant radiotherapy and chemotherapy for pancreatic carcinoma: the Mayo Clinic experience (1975-2005). J Clin Oncol 2008; 26: 3511-3516.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3511-3516
-
-
Corsini, M.M.1
Miller, R.C.2
Haddock, M.G.3
-
12
-
-
49049097155
-
Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the panceas: Results of a large, prospectively collected database at the Johns Hopkins Hospital
-
Herman JM, Swartz MJ, Hsu CC, et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the panceas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol 2008; 26: 3503-3510.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3503-3510
-
-
Herman, J.M.1
Swartz, M.J.2
Hsu, C.C.3
-
13
-
-
0037208652
-
Prognostic factors following curative resection for pancreatic adenocarcinoma: A population-based, linked database analysis of 396 patients
-
Lim JE, Chien MW, Earle CC. Prognostic factors following curative resection for pancreatic adenocarcinoma: a population-based, linked database analysis of 396 patients. Ann Surg 2003; 237: 74-85.
-
(2003)
Ann Surg
, vol.237
, pp. 74-85
-
-
Lim, J.E.1
Chien, M.W.2
Earle, C.C.3
-
14
-
-
51649126682
-
Adjuvant therapy for adenocarcinoma of the pancreas: Analysis of reported trials and recommendations for future progress
-
Wolff RA, Varadhachary GR, Evans DB. Adjuvant therapy for adenocarcinoma of the pancreas: analysis of reported trials and recommendations for future progress. Ann Surg Oncol 2008; 15: 2773-2786.
-
(2008)
Ann Surg Oncol
, vol.15
, pp. 2773-2786
-
-
Wolff, R.A.1
Varadhachary, G.R.2
Evans, D.B.3
-
15
-
-
0038644769
-
Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience
-
Richter A, Niedergethmann M, Sturm JW, et al. Long-term results of partial pancreaticoduodenectomy for ductal adenocarcinoma of the pancreatic head: 25-year experience. World J Surg 2003; 27: 324-329.
-
(2003)
World J Surg
, vol.27
, pp. 324-329
-
-
Richter, A.1
Niedergethmann, M.2
Sturm, J.W.3
-
16
-
-
12244262770
-
Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: A retrospective, single-institution experience
-
Takai S, Satoi S, Toyokawa H, Yanagimoto H, et al. Clinicopathologic evaluation after resection for ductal adenocarcinoma of the pancreas: a retrospective, single-institution experience. Pancreas 2003; 26: 243-249.
-
(2003)
Pancreas
, vol.26
, pp. 243-249
-
-
Takai, S.1
Satoi, S.2
Toyokawa, H.3
Yanagimoto, H.4
-
17
-
-
33751212765
-
1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience
-
Winter JM, Cameron JL, Campbell KA, et al. 1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience. J Gastrointest Surg 2006; 10: 1199-1210.
-
(2006)
J Gastrointest Surg
, vol.10
, pp. 1199-1210
-
-
Winter, J.M.1
Cameron, J.L.2
Campbell, K.A.3
-
18
-
-
1242293827
-
Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients
-
Kuhlmann KF, de Castro SM, Wesseling JG, et al. Surgical treatment of pancreatic adenocarcinoma; actual survival and prognostic factors in 343 patients. Eur J Cancer 2004; 40: 549-558.
-
(2004)
Eur J Cancer
, vol.40
, pp. 549-558
-
-
Kuhlmann, K.F.1
de Castro, S.M.2
Wesseling, J.G.3
-
19
-
-
33845398824
-
A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer
-
Howard TJ, Krug JE, Yu J, et al. A margin-negative R0 resection accomplished with minimal postoperative complications is the surgeon's contribution to long-term survival in pancreatic cancer. J Gastrointest Surg 2006; 10: 1338-1345.
-
(2006)
J Gastrointest Surg
, vol.10
, pp. 1338-1345
-
-
Howard, T.J.1
Krug, J.E.2
Yu, J.3
-
20
-
-
49049101358
-
Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head
-
Evans DB, Varadhachary GR, Crane CH, et al. Preoperative gemcitabine-based chemoradiation for patients with resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008; 26: 3496-3502.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3496-3502
-
-
Evans, D.B.1
Varadhachary, G.R.2
Crane, C.H.3
-
21
-
-
49049102131
-
Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head
-
Varadhachary GR, Wolff RA, Crane CH, et al. Preoperative gemcitabine and cisplatin followed by gemcitabine-based chemoradiation for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008; 26: 3487-3495.
-
(2008)
J Clin Oncol
, vol.26
, pp. 3487-3495
-
-
Varadhachary, G.R.1
Wolff, R.A.2
Crane, C.H.3
-
22
-
-
0026454511
-
Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas
-
Evans DB, Rich TA, Byrd DR, et al. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas. Arch Surg 1992; 127: 1335-1339.
-
(1992)
Arch Surg
, vol.127
, pp. 1335-1339
-
-
Evans, D.B.1
Rich, T.A.2
Byrd, D.R.3
-
23
-
-
0031972708
-
Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: An Eastern Cooperative Oncology Group Study
-
Hoffman JP, Lipsitz S, Pisansky T, et al. Phase II trial of preoperative radiation therapy and chemotherapy for patients with localized, resectable adenocarcinoma of the pancreas: an Eastern Cooperative Oncology Group Study. J Clin Oncol 1998; 16: 317-323.
-
(1998)
J Clin Oncol
, vol.16
, pp. 317-323
-
-
Hoffman, J.P.1
Lipsitz, S.2
Pisansky, T.3
-
24
-
-
0032421150
-
Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma
-
Pisters PW, Abbruzzese JL, Janjan NA, et al. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma. J Clin Oncol 1998; 16: 3843-3850.
-
(1998)
J Clin Oncol
, vol.16
, pp. 3843-3850
-
-
Pisters, P.W.1
Abbruzzese, J.L.2
Janjan, N.A.3
-
25
-
-
18244369036
-
Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas
-
White RR, Hurwitz HI, Morse MA, et al. Neoadjuvant chemoradiation for localized adenocarcinoma of the pancreas. Ann Surg Oncol 2001; 8: 758-765.
-
(2001)
Ann Surg Oncol
, vol.8
, pp. 758-765
-
-
White, R.R.1
Hurwitz, H.I.2
Morse, M.A.3
-
26
-
-
0036704413
-
A phase II single institutional experience with preoperative radiochemotherapy in pancreatic adenocarcinoma
-
Moutardier V, Giovannini M, Lelong B, et al. A phase II single institutional experience with preoperative radiochemotherapy in pancreatic adenocarcinoma. Eur J Surg Oncol 2002; 28: 531-539.
-
(2002)
Eur J Surg Oncol
, vol.28
, pp. 531-539
-
-
Moutardier, V.1
Giovannini, M.2
Lelong, B.3
-
27
-
-
0036549518
-
Preoperative chemoradiation in the management of adenocarcinoma of the body of the pancreas
-
Arnoletti JP, Hoffman JP, Ross EA, et al. Preoperative chemoradiation in the management of adenocarcinoma of the body of the pancreas. Am Surg 2002; 68: 330-335.
-
(2002)
Am Surg
, vol.68
, pp. 330-335
-
-
Arnoletti, J.P.1
Hoffman, J.P.2
Ross, E.A.3
-
28
-
-
0037092960
-
Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: Toxicities, histologic response rates, and event-free outcome
-
Pisters PW, Wolff RA, Janjan NA, et al. Preoperative paclitaxel and concurrent rapid-fractionation radiation for resectable pancreatic adenocarcinoma: toxicities, histologic response rates, and event-free outcome. J Clin Oncol 2002; 20: 2537-2544.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2537-2544
-
-
Pisters, P.W.1
Wolff, R.A.2
Janjan, N.A.3
-
29
-
-
0242500947
-
Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer
-
Magnin V, Moutardier V, Giovannini MH, et al. Neoadjuvant preoperative chemoradiation in patients with pancreatic cancer. Int J Radiat Oncol Biol Phys 2003; 55: 1300-1304.
-
(2003)
Int J Radiat Oncol Biol Phys
, vol.55
, pp. 1300-1304
-
-
Magnin, V.1
Moutardier, V.2
Giovannini, M.H.3
-
30
-
-
31544438080
-
A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma
-
Talamonti MS, Small W, Jr., Mulcahy MF, et al. A multi-institutional phase II trial of preoperative full-dose gemcitabine and concurrent radiation for patients with potentially resectable pancreatic carcinoma. Ann Surg Oncol 2006; 13: 150-158.
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 150-158
-
-
Talamonti, M.S.1
Small Jr., W.2
Mulcahy, M.F.3
-
31
-
-
45149091560
-
Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head
-
Heinrich S, Pestalozzi BC, Schafer M, et al. Prospective phase II trial of neoadjuvant chemotherapy with gemcitabine and cisplatin for resectable adenocarcinoma of the pancreatic head. J Clin Oncol 2008; 26: 2526-2531.
-
(2008)
J Clin Oncol
, vol.26
, pp. 2526-2531
-
-
Heinrich, S.1
Pestalozzi, B.C.2
Schafer, M.3
-
32
-
-
33748365398
-
Borderline resectable pancreatic cancer: Definitions, management, and role of preoperative therapy
-
Varadhachary GR, Tamm EP, Abbruzzese JL, et al. Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy. Ann Surg Oncol 2006; 13: 1035-1046.
-
(2006)
Ann Surg Oncol
, vol.13
, pp. 1035-1046
-
-
Varadhachary, G.R.1
Tamm, E.P.2
Abbruzzese, J.L.3
-
33
-
-
43049106807
-
Borderline resectable pancreatic cancer: The importance of this emerging stage of disease
-
Katz MH, Pisters PW, Evans DB, et al. Borderline resectable pancreatic cancer: the importance of this emerging stage of disease. J Am Coll Surg 2008; 206: 833-846.
-
(2008)
J Am Coll Surg
, vol.206
, pp. 833-846
-
-
Katz, M.H.1
Pisters, P.W.2
Evans, D.B.3
-
34
-
-
67649213557
-
AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: Rationale and overview of the conference
-
Vauthey JN, Dixon E. AHPBA/SSO/SSAT Consensus Conference on Resectable and Borderline Resectable Pancreatic Cancer: rationale and overview of the conference. Ann Surg Oncol 2009; 16: 1725-1726.
-
(2009)
Ann Surg Oncol
, vol.16
, pp. 1725-1726
-
-
Vauthey, J.N.1
Dixon, E.2
-
35
-
-
75449086813
-
Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer
-
McClaine RJ, Lowy AM, Sussman JJ, et al. Neoadjuvant therapy may lead to successful surgical resection and improved survival in patients with borderline resectable pancreatic cancer. HPB 2010; 12: 73-79.
-
(2010)
HPB
, vol.12
, pp. 73-79
-
-
McClaine, R.J.1
Lowy, A.M.2
Sussman, J.J.3
-
36
-
-
79959928329
-
Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer
-
Patel M, Hoffe S, Malafa M, et al. Neoadjuvant GTX chemotherapy and IMRT-based chemoradiation for borderline resectable pancreatic cancer. J Surg Oncol 2011; 104: 155-161.
-
(2011)
J Surg Oncol
, vol.104
, pp. 155-161
-
-
Patel, M.1
Hoffe, S.2
Malafa, M.3
-
37
-
-
0036761353
-
Large core biopsy of the pancreas under CT fluoroscopy control: Results and complications
-
Zech CJ, Helmberger T, Wichmann MW, et al. Large core biopsy of the pancreas under CT fluoroscopy control: results and complications. J Comput Assist Tomogr 2002; 26: 743-749.
-
(2002)
J Comput Assist Tomogr
, vol.26
, pp. 743-749
-
-
Zech, C.J.1
Helmberger, T.2
Wichmann, M.W.3
-
38
-
-
0021959822
-
Malignant seeding after fine-needle aspiration biopsy of the pancreas
-
Caturelli E, Rapaccini GL, Anti M, et al. Malignant seeding after fine-needle aspiration biopsy of the pancreas. Diagn Imaging Clin Med 1985; 54: 88-91.
-
(1985)
Diagn Imaging Clin Med
, vol.54
, pp. 88-91
-
-
Caturelli, E.1
Rapaccini, G.L.2
Anti, M.3
-
39
-
-
0037263729
-
Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer
-
Raut CP, Grau AM, Staerkel GA, et al. Diagnostic accuracy of endoscopic ultrasound-guided fine-needle aspiration in patients with presumed pancreatic cancer. J Gastrointest Surg 2003; 7: 118-126.
-
(2003)
J Gastrointest Surg
, vol.7
, pp. 118-126
-
-
Raut, C.P.1
Grau, A.M.2
Staerkel, G.A.3
-
40
-
-
58549092991
-
Endoscopic ultrasound guided fine needle aspiration of solid pancreatic lesions: Performance and outcomes
-
Fisher L, Segarajasingam DS, Stewart C, et al. Endoscopic ultrasound guided fine needle aspiration of solid pancreatic lesions: Performance and outcomes. J Gastroenterol Hepatol 2009; 24: 90-96.
-
(2009)
J Gastroenterol Hepatol
, vol.24
, pp. 90-96
-
-
Fisher, L.1
Segarajasingam, D.S.2
Stewart, C.3
-
41
-
-
0034943081
-
Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients
-
Pisters PW, Hudec WA, Hess KR, et al. Effect of preoperative biliary decompression on pancreaticoduodenectomy-associated morbidity in 300 consecutive patients. Ann Surg 2001; 234: 47-55.
-
(2001)
Ann Surg
, vol.234
, pp. 47-55
-
-
Pisters, P.W.1
Hudec, W.A.2
Hess, K.R.3
-
42
-
-
60549090130
-
Relationship of postoperative complications from preoperative biliary stents after pancreaticoduodenectomy. A new cohort analysis and meta-analysis of modern studies
-
Velanovich V, Kheibek T, Khan M. Relationship of postoperative complications from preoperative biliary stents after pancreaticoduodenectomy. A new cohort analysis and meta-analysis of modern studies. JOP 2009; 10: 24-29.
-
(2009)
JOP
, vol.10
, pp. 24-29
-
-
Velanovich, V.1
Kheibek, T.2
Khan, M.3
-
43
-
-
83355169753
-
Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: A phase I/II trial
-
Von Hoff DD, Ramanathan RK, Borad MJ, et al. Gemcitabine plus nab-paclitaxel is an active regimen in patients with advanced pancreatic cancer: a phase I/II trial. J Clin Oncol 2011; 29: 4548-4554.
-
(2011)
J Clin Oncol
, vol.29
, pp. 4548-4554
-
-
von Hoff, D.D.1
Ramanathan, R.K.2
Borad, M.J.3
-
44
-
-
79955921754
-
FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer
-
Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med 2011; 364: 1817-1825.
-
(2011)
N Engl J Med
, vol.364
, pp. 1817-1825
-
-
Conroy, T.1
Desseigne, F.2
Ychou, M.3
-
45
-
-
80051613675
-
Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: Correlation of Smad4(Dpc4) immunostaining with pattern of disease progression
-
Crane CH, Varadhachary GR, Yordy JS, et al. Phase II trial of cetuximab, gemcitabine, and oxaliplatin followed by chemoradiation with cetuximab for locally advanced (T4) pancreatic adenocarcinoma: correlation of Smad4(Dpc4) immunostaining with pattern of disease progression. J Clin Oncol 2011; 29: 3037-3043.
-
(2011)
J Clin Oncol
, vol.29
, pp. 3037-3043
-
-
Crane, C.H.1
Varadhachary, G.R.2
Yordy, J.S.3
-
46
-
-
77954032829
-
Poly(ADP)-ribose polymerase inhibition: Frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval
-
Fong PC, Yap TA, Boss DS, et al. Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval. J Clin Oncol 2010; 28: 2512-2519.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2512-2519
-
-
Fong, P.C.1
Yap, T.A.2
Boss, D.S.3
-
47
-
-
67149143399
-
Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer
-
Olive KP, Jacobetz MA, Davidson CJ, et al. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009; 324: 1457-1461.
-
(2009)
Science
, vol.324
, pp. 1457-1461
-
-
Olive, K.P.1
Jacobetz, M.A.2
Davidson, C.J.3
-
48
-
-
70249130566
-
Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411
-
Crane CH, Winter K, Regine WF, et al. Phase II study of bevacizumab with concurrent capecitabine and radiation followed by maintenance gemcitabine and bevacizumab for locally advanced pancreatic cancer: Radiation Therapy Oncology Group RTOG 0411. J Clin Oncol 2009; 27: 4096-4102.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4096-4102
-
-
Crane, C.H.1
Winter, K.2
Regine, W.F.3
-
49
-
-
29044433659
-
Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: A phase I study
-
Iannitti D, Dipetrillo T, Akerman P, et al. Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study. Am J Clin Oncol 2005; 28: 570-575.
-
(2005)
Am J Clin Oncol
, vol.28
, pp. 570-575
-
-
Iannitti, D.1
Dipetrillo, T.2
Akerman, P.3
-
50
-
-
84855858203
-
Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer
-
Robertson JM, Margolis J, Jury RP, et al. Phase I study of conformal radiotherapy and concurrent full-dose gemcitabine with erlotinib for unresected pancreatic cancer. Int J Radiat Oncol Biol Phys 2012; 82: e187-e192.
-
(2012)
Int J Radiat Oncol Biol Phys
, vol.82
-
-
Robertson, J.M.1
Margolis, J.2
Jury, R.P.3
-
51
-
-
0027383812
-
Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation
-
Peter RU, Beetz A, Ried C, et al. Increased expression of the epidermal growth factor receptor in human epidermal keratinocytes after exposure to ionizing radiation. Radiat Res 1993; 136: 65-70.
-
(1993)
Radiat Res
, vol.136
, pp. 65-70
-
-
Peter, R.U.1
Beetz, A.2
Ried, C.3
-
52
-
-
0030772168
-
Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation
-
Schmidt-Ullrich RK, Mikkelsen RB, Dent P, et al. Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation. Oncogene 1997; 15: 1191-1197.
-
(1997)
Oncogene
, vol.15
, pp. 1191-1197
-
-
Schmidt-Ullrich, R.K.1
Mikkelsen, R.B.2
Dent, P.3
-
53
-
-
0033966576
-
In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody
-
Milas L, Mason K, Hunter N, et al. In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody. Clin Cancer Res 2000; 6: 701-708.
-
(2000)
Clin Cancer Res
, vol.6
, pp. 701-708
-
-
Milas, L.1
Mason, K.2
Hunter, N.3
-
54
-
-
65549150854
-
Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer
-
Van Cutsem E, Vervenne WL, Bennouna J, et al. Phase III trial of bevacizumab in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer. J Clin Oncol 2009; 27: 2231-2237.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2231-2237
-
-
van Cutsem, E.1
Vervenne, W.L.2
Bennouna, J.3
-
55
-
-
77949553030
-
Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation
-
McGee MC, Hamner JB, Williams RF, et al. Improved intratumoral oxygenation through vascular normalization increases glioma sensitivity to ionizing radiation. Int J Radiat Oncol Biol Phys 2010; 76: 1537-1545.
-
(2010)
Int J Radiat Oncol Biol Phys
, vol.76
, pp. 1537-1545
-
-
McGee, M.C.1
Hamner, J.B.2
Williams, R.F.3
-
56
-
-
79953154967
-
CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans
-
Beatty GL, Chiorean EG, Fishman MP, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science 2011; 331: 1612-1616.
-
(2011)
Science
, vol.331
, pp. 1612-1616
-
-
Beatty, G.L.1
Chiorean, E.G.2
Fishman, M.P.3
|